Outcomes of tafasitamab and lenalidomide in large B-cell lymphoma based on prior CD19-directed CAR T exposure.

ABSTRACT:

SUBMITTER: Merrill MH 

PROVIDER: S-EPMC12626236 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature